Japan's Patent Office Issues Replicel Two New Patents For Its Regenerative Medicine Technologies

Rumspringa!

Member
My Regimen
Reaction score
53
Japan's Patent Office issues RepliCel two new patents for its regenerative medicine technologies. The granting of these two patents for large-market clinical applications is key to RepliCel's first-in-Japan strategy announced March 2019.
 
Top